Q9UGN5 (PARP2_HUMAN) Homo sapiens (Human)
Poly [ADP-ribose] polymerase 2 UniProtKBInterProSTRINGInteractive Modelling
583 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
25 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Bridging of double-strand DNA break activates PARP2/HPF1 to modify chromatin |
Heteromer Q9NWY4; | 100.0 | ||||
| Bridging of double-strand DNA break activates PARP2/HPF1 to modify chromatin |
Heteromer P02281; P06897; P62799; P84233; Q9NWY4; | 100.0 | ||||
| Bridging of double-strand DNA break activates PARP2/HPF1 to modify chromatin |
Heteromer Q9NWY4; | 100.0 | ||||
| HPF1 bound to catalytic fragment of PARP2 |
Heteromer Q9NWY4; | 17.65 | 1×UHB; | |||
| Structure of two nucleosomes bridged by human PARP2 |
Heteromer P04908; P06899; P62805; P68431; | 98.25 | ||||
| Crystal Structure NLS from human PARP-2 complexed with Importin alpha delta IBB |
Heteromer P52293; | 100.0 | ||||
| Structure of ARTD2/PARP2 WGR domain bound to double strand DNA without 5'phosphate | homo-6-mer | 100 | 6×GOL; 6×CL; | |||
| Human ARTD2 in complex with DNA oligonucleotides | homo-2-mer | 100.0 | 4×SO4; | |||
| Structure of ARTD2/PARP2 WGR domain bound to double strand DNA with 5 nucleotide overhang and 5'pho… | homo-2-mer | 100 | ||||
| Structure of ARTD2/PARP2 WGR domain bound to double stranded DNA with 5'phosphate | homo-2-mer | 100 | ||||
| Structure of PARP2 catalytic domain bound to an isoindolinone inhibitor | monomer | 100.0 | 1×FSU; | |||
| Structure of human PARP2 catalytic domain bound to an isoindolinone inhibitor | monomer | 100.0 | 1×D7N; | |||
| Mutated human ADP-ribosyltransferase 2 (PARP2) catalytic domain bound to Rucaparib | monomer | 98.86 | 5×GOL; 1×RPB; | |||
| Mutated human ADP-ribosyltransferase 2 (PARP2) catalytic domain bound to approved drug Fluzoparib | monomer | 98.86 | 1×GOL; 1×25I; | |||
| Mutated human ADP-ribosyltransferase 2 (PARP2) catalytic domain bound to Niraparib (MK-4827) | monomer | 98.86 | 1×GOL; 1×3JD; | |||
| Mutated human ADP-ribosyltransferase 2 (PARP2) catalytic domain bound to Pamiparib(BGB-290) | monomer | 98.86 | 2×GOL; 1×DS9; | |||
| Mutated human ADP-ribosyltransferase 2 (PARP2) catalytic domain bound to a pyrazolopyrimidine carbo… | monomer | 98.86 | 1×ERV; | |||
| Human ADP-ribosyltransferase 2 (PARP2) catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inh… | monomer | 98.86 | 1×GOL; 1×1WI; | |||
| Mutated human ADP-ribosyltransferase 2 (PARP2) catalytic domain bound to Olaparib (AZD2281) | monomer | 98.86 | 1×09L; | |||
| Human poly(ADP-ribose) polymerase 2, catalytic fragment in complex with an inhibitor ABT-888 | monomer | 99.71 | 1×78P; 1×GOL; | |||
| PARP2 catalytic domain in complex with OUL245 | monomer | 99.71 | 1×GOL; 1×I5F; | |||
| Human poly(ADP-ribose) polymerase 2, catalytic fragment in complex with an inhibitor 3-aminobenzami… | monomer | 99.71 | 1×3AB; 1×GOL; | |||
| HUMAN ARTD2 (PARP2) - CATALYTIC DOMAIN IN COMPLEX WITH OLAPARIB | monomer | 99.71 | 1×09L; 2×GOL; | |||
| Structure of PARP2 catalytic domain bound to inhibitor BMN 673 | monomer | 99.7 | 1×2YQ; 2×GOL; | |||
| Crystal structure of constitutively active PARP-2 | monomer | 100 | 1×UHB; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6x0l.1.B | monomer | 0.76 | 100.00 | |||
| 6tx3.1.A | monomer | 0.75 | 1×UHB; | 91.15 | ||
2 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 6x0l.1.B | monomer | 0.79 | 100.00 | |||
| Isoform 2 | 6tx3.1.A | monomer | 0.75 | 1×UHB; | 91.15 | ||